As of the latest Form 4 filed Jul 2, 2026.
What Kestra Medical Technologies, Ltd. Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 14 most recent filings for KMTS.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-06-30 | Moran Timothy P. Chief Business Officer | AAward | +227.00 | $21.55 | $4.89K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Umberger Traci S See Remarks | AAward | +942.00 | $21.55 | $20.3K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Webster Brian Daniel See Remarks | SSale | −15.0K | $20.81 | $312K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Moran Timothy P. Chief Business Officer | AAward | +22.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Ford Alfred J Jr Chief Commercial Officer | AAward | +25.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Mahboob Vaseem Chief Financial Officer | AAward | +25.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Umberger Traci S See Remarks | AAward | +25.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Webster Brian Daniel See Remarks | AAward | +75.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Webster Brian Daniel See Remarks | SSale | −6.84K | $21.46 | $147K | Yes (planned) | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Webster Brian Daniel, See Remarks | SSale | −8.15K | $20.53 | $167K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Webster Brian Daniel See Remarks | SSale | −15.0K | $20.04 | $301K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | COHEN RAYMOND W Director | PPurchase | +10.0K | $19.98 | $200K | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-17 | Webster Brian Daniel See Remarks | SSale | −15.0K | $20.27 | $304K | Yes (planned) | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Reilly Kevin C Director | AAward | +8.30K | — | — | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also KMTS’s full analysis or the market-wide insider trading feed. The tabs above jump to KMTS’s other SEC data.
Source: SEC Form 4 filings for KMTS, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.